Clinical Trial

Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation

Study acronym: RND
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 16, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study design: Investigator initiated, single center The study is aimed 1\) To investigate the blood pressure (BP) change to renal nerve stimulation(RNS), and subsequently perform a renal denervation(RDN) procedure 1\) to verify the cutoff value (RNS-induced systolic BP change \<20 mmHg in post-RDN patients) could be a useful clinical endpoint in RDN therapy, and test the hypothesis that intense RDN could improve the efficacy of RDN.
Trial Details
NCT Number NCT05421767
Lead Sponsor National Taiwan University Hospital
Conditions Hypertension
Enrollment 60 participants
Start Date 2022-06-24
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-06-16